Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
Conditions:   Diabetes Mellitus;   Iron Metabolism Disorders;   Gastroduodenal Ulcer;   Optic Atrophy;   Sensorineural Hearing Loss;   Platelet Dysfunction Interventions:   Drug: Deferiprone;   Drug: Acetylcysteine;   Drug: Sitagliptin and Metformin Sponsor:   Hadassah Medical Organization Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2016 Category: Research Source Type: clinical trials

Glucose Homeostasis and Incretin Effect T2DM in the Youth- a Study of the Malaysian Population
< b > Condition < /b > :   Diabetes Mellitus, Type 2 < br/ > < b > Intervention < /b > :   Other: OGTT and IVGTT tests < br/ > < b > Sponsors < /b > :   Penang Medical College;   Sarawak General Hospital;   Putrajaya Hospital, Malaysia;   Penang Hospital, Malaysia;   Institute of Neuroscience, Padova, Italy;   University of Copenhagen;   Institute for Medical Research, Malaysia;   Seberang Jaya Clinical Research Cent re < br/ > < b > Completed < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2016 Category: Research Source Type: clinical trials